Associations of antibiotic use with risk of primary liver cancer in the Clinical Practice Research Datalink

Menée au Royaume-Uni à partir de données portant sur 1 195 cas et 4 640 témoins, cette étude évalue l'association entre une utilisation d'antibiotiques et le risque de cancer primitif du foie

Résumé en anglais

Background: Use of antibiotics could alter human microbiota composition and decrease bacterial diversity. Such microbial dysbiosis may have implications in hepatocarcinogenesis; however, the association between antibiotic use and liver cancer risk has been minimally examined in humans.

Methods: We performed a nested case–control study (1195 primary liver cancer cases and 4640 matched controls) within the United Kingdom’s Clinical Practice Research Datalink. Antibiotic use was obtained from prescription records. Multivariable-adjusted odds ratio (OR) and 95% confidence interval (CI) were estimated using conditional logistic regression.

Results: Ever-use of prescription antibiotics was associated with a slightly increased risk of liver cancer, compared to non-use (OR=1.22, 95% CI=1.03−1.45). However, there was no clear dose–response relationship by the number of prescriptions or cumulative dose of antibiotic use, suggesting a non-causal association.

Conclusions: Our results do not support a role of antibiotic use in liver cancer development.